Molecular Partners Ag (MOLN) EBT Margin (QoQ) (2020 - 2026)
Molecular Partners Ag (MOLN) EBT Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Molecular Partners Ag | 163.99 Mn | 163.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.40 Mn |
| Dec 31, 2025 | 14.40 Mn |
| Sep 30, 2025 | 1,953.00 |
| Jun 30, 2025 | -1,389.00 |
| Mar 31, 2025 | -109.77 Mn |
| Dec 31, 2024 | 109.76 Mn |
| Sep 30, 2024 | 97.24 Mn |
| Jun 30, 2024 | -97.20 Mn |
| Mar 31, 2024 | 49,555.00 |
| Dec 31, 2023 | -45,899.00 |
| Sep 30, 2023 | 340,211.00 |
| Jun 30, 2023 | -385,229.00 |
| Mar 31, 2023 | -8,213.00 |
| Dec 31, 2022 | 8,213.00 |
| Sep 30, 2022 | 3,846.00 |
| Jun 30, 2022 | -3,846.00 |
| Mar 31, 2022 | -80.00 |
| Dec 31, 2021 | 34,920.00 |
| Sep 30, 2021 | -35,183.00 |
| Jun 30, 2021 | 344.00 |